Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01545466 · ClinicalTrials.gov registry record · NA

Non-drug Interventions for Migraines

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT01545466: Completed NA study, sponsored by Brigham and Women's Hospital.

NCT01545466 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01545466, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

This proposal describes a randomized controlled pilot trial investigating feasibility, safety, and migraine frequency in patients with migraines who undergo an 8 week mindfulness based stress reduction (MBSR) program compared to a wait-list control group.

Primary Outcome

Change in the number of migraines per month from baseline(tracked with headache logs)

Interventions

  • BEHAVIORAL Mindfulness Based Stress Reduction (MBSR)

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2012-02
Est. Completion 2012-10
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT01545466 record still lists

NCT01545466 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Mindfulness Based Stress Reduction (MBSR) is the first listed.

NCT01545466 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01545466 about?

NCT01545466 is a clinical study titled "Non-drug Interventions for Migraines". This proposal describes a randomized controlled pilot trial investigating feasibility, safety, and migraine frequency in patients with migraines who undergo an 8 week mindfulness based stress reduction (MBSR) program compared to a wait-list control group.

What is the current status of trial NCT01545466?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2012-02. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01545466?

The interventions under investigation include: Mindfulness Based Stress Reduction (MBSR) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01545466?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01545466's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01545466, the US trial registry maintained by the National Library of Medicine. NCT01545466 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.